Combined Treatment With TGF-β1, Retinoic Acid, and Lactoferrin Robustly Generate Inducible Tregs (iTregs) Against High Affinity Ligand
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Forkhead box P3-positive (Foxp3+)-inducible Tregs (iTregs) are readily generated by TGF-β1 at low TCR signaling intensity. TGF-β1–mediated Foxp3 expression is further enhanced by retinoic acid (RA) and lactoferrin (LF). However, the intensity of TCR signaling required for induction of Foxp3 expression by TGF-β1 in combination with RA and LF is unknown. Here, we found that either RA or LF alone decreased TGF-β1–mediated Foxp3 expression at low TCR signaling intensity. In contrast, at high TCR signaling intensity, the addition of either RA or LF strongly increased TGF-β1–mediated Foxp3 expression. Moreover, decreased CD28 stimulation was more favorable for TGF-β1/LF–mediated Foxp3 expression. Lastly, we found that at high signaling intensities of both TCR and CD28, combined treatment with TGF-β1, RA, and LF induced robust expression of Foxp3, in parallel with powerful suppressive activity against responder T cell proliferation. Our findings that TGFβ/RA/LF strongly generate high affinity Ag-specific iTreg population would be useful for the control of unwanted hypersensitive immune reactions such as various autoimmune diseases.
Abstract
Forkhead box P3-positive (Foxp3+)-inducible Tregs (iTregs) are readily generated by TGF-β1 at low TCR signaling intensity. TGF-β1–mediated Foxp3 expression is further enhanced by retinoic acid (RA) and lactoferrin (LF). However, the intensity of TCR signaling required for induction of Foxp3 expression by TGF-β1 in combination with RA and LF is unknown. Here, we found that either RA or LF alone decreased TGF-β1–mediated Foxp3 expression at low TCR signaling intensity. In contrast, at high TCR signaling intensity, the addition of either RA or LF strongly increased TGF-β1–mediated Foxp3 expression. Moreover, decreased CD28 stimulation was more favorable for TGF-β1/LF–mediated Foxp3 expression. Lastly, we found that at high signaling intensities of both TCR and CD28, combined treatment with TGF-β1, RA, and LF induced robust expression of Foxp3, in parallel with powerful suppressive activity against responder T cell proliferation. Our findings that TGFβ/RA/LF strongly generate high affinity Ag-specific iTreg population would be useful for the control of unwanted hypersensitive immune reactions such as various autoimmune diseases.
참고문헌 (20)
- Chen W, "Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3", J Exp Med, 198, pp.1875~1886 (2003)
- Abbas AK, "Regulatory T cells : recommendations to simplify the nomenclature", Nat Immunol, 14, pp.307~308 (2013)
- Hori S, "Control of regulatory T cell development by the transcription factor Foxp3", Science, 299, pp.1057~1061 (2003)
- Tone Y, "Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer", Nat Immunol, 9, pp.194~202 (2008)
- Xiao S, "Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression", J Immunol, 181, pp.2277~2284 (2008)
- Xu L, "Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I", Immunity, 33, pp.313~325 (2010)
- Jang YS, "Lactoferrin potentiates inducible regulatory t cell differentiation through TGF-β receptor III binding and activation of membrane-bound TGF-β", J Immunol, 207, pp.2456~2464 (2021)
- Dong Y, "Post-translational regulations of foxp3 in Treg cells and their therapeutic applications", Front Immunol, 12, pp.626172~ (2021)
- Turner MS, "Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion", J Immunol, 183, pp.4895~4903 (2009)
- Sauer S, "T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR", Proc Natl Acad Sci U S A, 105, pp.7797~7802 (2008)
- Jang YS, "Lactoferrin-derived chimeric peptide(LFch)strongly boosts TGFβ1-mediated inducible Treg differentiation possibly through downregulating TCR", CD28 signalling, 2023, pp.168, 110~119
- Benson MJ, "All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation", J Exp Med, 204, pp.1765~1774 (2007)
- Mucida D, "Retinoic acid can directly promote TGF-beta-mediated Foxp3(+)Treg cell conversion of naive T cells", Immunity, 30, pp.471~472 (2009)
- Chen A, "Structural requirements regulate endoproteolytic release of the L-selectin(CD62L)adhesion receptor from the cell surface of leukocytes", J Exp Med, 182, pp.519~530 (1995)
- Jacobse J, "Intestinal regulatory t cells as specialized tissue-restricted immune cells in intestinal immune homeostasis and disease", Front Immunol, 12, pp.716499~ (2021)
- Konkel JE, "Balancing acts : the role of TGF-β in the mucosal immune system", Trends Mol Med, 17, pp.668~676 (2011)
- Manicassamy S, "Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages", Semin Immunol, 21, pp.22~27 (2009)
- Sun CM, "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid", J Exp Med, 204, pp.1775~1785 (2007)
- Mason DY, "Distribution of transferrin, ferritin, and lactoferrin in human tissues", J Clin Pathol, 31, pp.316~327 (1978)
- Sánchez-Fueyo A, "Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation", Am J Transplant, 20, pp.1125~1136 (2020)